Bio-Techne
TECH
#1769
Rank
S$14.72 B
Marketcap
S$93.75
Share price
-0.04%
Change (1 day)
24.17%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): S$1.51

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is S$1.51. In 2025 the company made an earnings per share (EPS) of S$0.67 a decrease over its 2024 EPS that were of S$1.29.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$1.51124.72%
2025S$0.67-48%
2024S$1.29-29.58%
2023S$1.83-14.97%
2022S$2.1524.16%
2021S$1.7417.98%
2020S$1.47-10.94%
2019S$1.65101.57%
2018S$0.82-16.99%
2017S$0.9945.02%
2016S$0.68-20.97%
2015S$0.86-14.97%
2014S$1.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
S$24.50 1,523.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
S$4.64 207.69%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$11.26 646.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
S$7.89 423.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
S$2.56 69.64%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
S-$0.27-117.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
S$49.23 3,161.54%๐Ÿ‡บ๐Ÿ‡ธ USA